← К результатам

CRISPR-Cas9 as a Trojan horse.

Monte DFM

Molecular therapy : the journal of the American Society of Gene Therapy, 31(10): 2817-2818 PMID 37607542 DOI 10.1016/j.ymthe.2023.08.005